Farooqi IS

Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials

Karine Clément, van den Akker E, Jesús Argente et al. · Yearbook of pediatric endocrinology · 2021 · 16 citations

Mc4r Agonist, Bariatric Surgery, Weight Management +16

MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency

Karine Clément, Heike Biebermann, Farooqi IS et al. · Yearbook of pediatric endocrinology · 2018 · 11 citations

Nutrition, Metabolic Disorder, Weight Regulation +20

Human gain-of-function MC4R variants show signaling bias and protect against obesity

Lotta LA, Jacek Mokrosiński, Mendes de Oliveira E et al. · Yearbook of pediatric endocrinology · 2020 · 10 citations

Phenotypic Variation, Recent Gwas, Genetics +26

Obesity-associated GNAS mutations and the melanocortin pathway

Mendes de Oliveira E, Keogh JM, F Talbot et al. · Yearbook of pediatric endocrinology · 2022 · 10 citations